United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2972_fdab7199-a313-47a6-9a5a-fc1b27a402d2
- Product NDC
- 71335-2972
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250619
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-1) · 71335-2972-1
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-2) · 71335-2972-2
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-3) · 71335-2972-3
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-4) · 71335-2972-4
- 15 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-5) · 71335-2972-5
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-6) · 71335-2972-6
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-7) · 71335-2972-7
- 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-8) · 71335-2972-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →